Cite

HARVARD Citation

    Garcia-Cañibano, B. et al. (2021). Real-world experience of ocrelizumab in multiple sclerosis in an Arab population. Journal of drug assessment. 10 (1), pp. 106-113. [Online]. 
  
Back to record